1. Home
  2. GLDG vs STTK Comparison

GLDG vs STTK Comparison

Compare GLDG & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoldMining Inc.

GLDG

GoldMining Inc.

HOLD

Current Price

$1.37

Market Cap

279.0M

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.30

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDG
STTK
Founded
2009
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.0M
119.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GLDG
STTK
Price
$1.37
$3.30
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$3.50
$4.00
AVG Volume (30 Days)
2.2M
424.7K
Earning Date
10-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.69
52 Week High
$1.80
$3.38

Technical Indicators

Market Signals
Indicator
GLDG
STTK
Relative Strength Index (RSI) 50.42 71.09
Support Level $1.32 $2.82
Resistance Level $1.41 $3.29
Average True Range (ATR) 0.08 0.24
MACD -0.00 -0.00
Stochastic Oscillator 42.31 82.14

Price Performance

Historical Comparison
GLDG
STTK

About GLDG GoldMining Inc.

GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: